COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death
- PMID: 33331600
- DOI: 10.1590/S1679-49742021000100023
COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death
Abstract
Objective: To describe the clinical and epidemiological profile of suspected COVID-19 cases admitted to a federal hospital in Rio de Janeiro, RJ, Brazil, and to identify factors associated with death.
Methods: This was a cross-sectional study using local epidemiological surveillance data as at epidemiological week 27 of 2020 and logistic regression.
Results: 376 hospitalized suspected COVID-19 cases were included; 52.9% were female, 57.4% were 50 years old or over and 80.1% had comorbidities. 195 (51.9%) COVID-19 cases were confirmed and their lethality was higher (37.9%) than among discarded cases (24.2%). In the adjusted analysis, death among confirmed cases was associated with being in the 50-69 age group (OR=11.65 - 95%CI 1.69;80.33), being aged 70 or over (OR=8.43 - 95%CI 1.22;58.14), presence of neoplasms (OR=4.34 - 95%CI 1.28;14.76) and use of invasive ventilatory support (OR=70.20 - 95%CI 19.09;258.19).
Conclusion: High prevalence of comorbidities and lethality was found; the main factors associated with death were being older, neoplasms and invasive ventilatory support.
Objetivo: Descrever o perfil clínico-epidemiológico dos casos suspeitos de COVID-19 internados em hospital federal do Rio de Janeiro, RJ, Brasil, e identificar fatores associados ao óbito.
Métodos: Estudo seccional, utilizando dados da vigilância epidemiológica local até a Semana Epidemiológica 27 de 2020. Empregou-se regressão logística.
Resultados: Foram incluídos 376 casos internados suspeitos de COVID-19, dos quais 52,9% eram mulheres, 57,4% tinham 50 anos ou mais de idade e 80,1% exibiam comorbidades. Foram confirmados para COVID-19 195 casos (51,9%), cuja letalidade (37,9%) foi maior, comparada à dos descartados (24,2%). Na análise ajustada, associaram-se ao óbito, nos casos confirmados, ter 50 a 69 (OR=11,65 – IC95% 1,69;80,33) e 70 ou mais anos (OR=8,43 – IC95% 1,22;58,14), apresentar neoplasia (OR=4,34 – IC95% 1,28;14,76) e usar suporte ventilatório invasivo (OR=70,20 – IC95% 19,09;258,19).
Conclusão: Houve elevada prevalência de comorbidades e letalidade; os principais fatores associados ao óbito foram idade, presença de neoplasia e suporte ventilatório invasivo.
Objetivo: Describir el perfil clínico-epidemiológico de casos sospechosos de COVID-19 ingresados en hospital federal de Río de Janeiro, RJ, Brasil, y factores asociados al óbito.
Métodos: Estudio transversal utilizando datos de la vigilancia epidemiológica local de casos sospechosos hospitalizados hasta la Semana Epidemiológica 27 de 2020 y regresión logística.
Resultados: Se incluyeron 376 casos, de los cuales 52,9% era de mujeres, 57,4% tenía 50 años o más, 80,1% tenía comorbilidades. Se confirmó para COVID-19 un 51,9% . Los casos confirmados tuvieron una mayor letalidad (37,9%) que los descartados (24,2%). La mortalidad ajustada en los confirmados fue mayor en los grupos de edad de 50 a 69 años (OR=11,65 – IC95% 1,69; 80,33), 70 años o más (OR=8,43 – IC95% 1,22;58,14), con neoplasia (OR=4,34 - IC95% 1,28;14,76) y uso de soporte ventilatorio invasivo (OR=70,20 – IC95% 19,09;258,19).
Conclusión: La mayor mortalidad se asoció con personas de edad avanzada, con neoplasias y uso de soporte ventilatorio invasivo.
Similar articles
-
Fatores associados ao óbito em casos confirmados de COVID-19 no estado do Rio de Janeiro.BMC Infect Dis. 2021 Jul 16;21(1):687. doi: 10.1186/s12879-021-06384-1. BMC Infect Dis. 2021. PMID: 34271868 Free PMC article.
-
COVID-19 hospitalizations in Brazil's Unified Health System (SUS).PLoS One. 2020 Dec 10;15(12):e0243126. doi: 10.1371/journal.pone.0243126. eCollection 2020. PLoS One. 2020. PMID: 33301479 Free PMC article.
-
Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data.Cancer. 2021 Nov 15;127(22):4240-4248. doi: 10.1002/cncr.33832. Epub 2021 Aug 3. Cancer. 2021. PMID: 34343344 Free PMC article.
-
High discrepancies in the mortality of hospitalized patients with COVID-19 in the two most economically important states in Brazil.Rev Bras Epidemiol. 2021 Dec 1;24:e210056. doi: 10.1590/1980-549720210056. eCollection 2021 Sep 1. Rev Bras Epidemiol. 2021. PMID: 34877997
-
The interaction between cancer and COVID-19: Risk factors and targeted interventions.PLoS One. 2025 Jun 3;20(6):e0319970. doi: 10.1371/journal.pone.0319970. eCollection 2025. PLoS One. 2025. PMID: 40460145 Free PMC article.
Cited by
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
SARS due to COVID-19: Predictors of death and profile of adult patients in the state of Rio de Janeiro, 2020.PLoS One. 2022 Nov 10;17(11):e0277338. doi: 10.1371/journal.pone.0277338. eCollection 2022. PLoS One. 2022. PMID: 36355856 Free PMC article.
-
Risk assessment and rationalization of health resource allocation: Lessons from the Brazilian COVID-19 cohort in 2020.Prev Med Rep. 2022 Apr;26:101724. doi: 10.1016/j.pmedr.2022.101724. Epub 2022 Feb 2. Prev Med Rep. 2022. PMID: 35132372 Free PMC article. No abstract available.
-
Fatores associados ao óbito em casos confirmados de COVID-19 no estado do Rio de Janeiro.BMC Infect Dis. 2021 Jul 16;21(1):687. doi: 10.1186/s12879-021-06384-1. BMC Infect Dis. 2021. PMID: 34271868 Free PMC article.
-
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563. Pathogens. 2022. PMID: 35631084 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical